CCL
89
-3
CMA
65
-6
DLTR
55
-3
MCK
69
2
ORLY
43
2
NRG
50
5
SNA
55
2
PEP
29
-3
AVGO
42
7
FTI
68
4
MCD
42
-4
DG
68
-6
JPM
73
2
M
49
-4
EA
47
3
SWKS
46
-2
OKE
67
2
JBHT
62
-3
NWSA
82
3
GIS
52
-5
CCL
89
-3
CMA
65
-6
DLTR
55
-3
MCK
69
2
ORLY
43
2
NRG
50
5
SNA
55
2
PEP
29
-3
AVGO
42
7
FTI
68
4
MCD
42
-4
DG
68
-6
JPM
73
2
M
49
-4
EA
47
3
SWKS
46
-2
OKE
67
2
JBHT
62
-3
NWSA
82
3
GIS
52
-5
Financhill
Back

RiverNorth Opportunities Fund Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
72

RIV
RiverNorth Opportunities Fund

Last Price:
$11.74
Seasonality Move:
-3.12%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.68
Seasonality Move:
25.93%
Buy
72
RiverNorth Opportunities Fund (RIV) is a Buy

Is RiverNorth Opportunities Fund a Buy, Sell or Hold?

  • The current RiverNorth Opportunities Fund [RIV] share price is $11.67. The Score for RIV is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RIV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.50. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RIV Stock Price Chart

What is RiverNorth Opportunities Fund's stock price today?

  • The RiverNorth Opportunities Fund share price today is $11.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIV is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

RIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.6 Buy
Relative Strength Index (14 RSI): 49.62 Sell
Chaikin Money Flow: -30026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.4 - 11.84) Buy
Bollinger Bands (100): (11.55 - 12.27) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.48 Sell
Relative Strength Index (14 RSI): 40.78 Sell
Chaikin Money Flow: -194871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.3 - 85.58) Sell
Bollinger Bands (100): (46.5 - 89.48) Buy

RIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.73 Sell
20-day SMA: 11.71 Sell
50-day SMA: 11.61 Buy
200-day SMA: 11.88 Sell
8-day EMA: 7.41 Buy
20-day EMA: 3.86 Buy
50-day EMA: 1.73 Buy
200-day EMA: 0.46 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.62 Sell
20-day SMA: 76.51 Sell
50-day SMA: 80.5 Sell
200-day SMA: 52.75 Buy
8-day EMA: 71.14 Sell
20-day EMA: 74.96 Sell
50-day EMA: 76.33 Sell
200-day EMA: 56.96 Buy

RiverNorth Opportunities Fund Earnings Growth & RIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

RiverNorth Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):